Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find the latest news about Kura Oncology aggregated by PharmaCompass.com.

    Client Virtual Booth

    KURA ONCOLOGY

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Kura Oncology
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Kura Oncology, Inc. (Headquarters) 3033 Science Park Road, Suite 220 San Diego, CA 92121
    Telephone
    Telephone
    (858) 500-8800
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://kuraoncology.com/
    Linkedin
    Linkedin
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Kura Oncology to Report First Quarter 2024 Financial Results
    Kura Oncology to Report First Quarter 2024 Financial Results

    https://www.globenewswire.com/news-release/2024/04/25/2869528/35186/en/Kura-Oncology-to-Report-First-Quarter-2024-Financial-Results.html

    GLOBENEWSWIRE
    25 Apr 2024
    Share Share
    Kura Gets Ziftomenib BTD In NPM1-Mutant AML
    Kura Gets Ziftomenib BTD In NPM1-Mutant AML

    https://www.globenewswire.com/news-release/2024/04/22/2866763/35186/en/Kura-Oncology-Receives-Breakthrough-Therapy-Designation-for-Ziftomenib-in-NPM1-Mutant-AML.html

    GLOBENEWSWIRE
    22 Apr 2024
    Share Share
    Kura Oncology to Participate in Stifel Targeted Oncology Forum
    Kura Oncology to Participate in Stifel Targeted Oncology Forum

    https://www.globenewswire.com/news-release/2024/04/10/2860648/35186/en/Kura-Oncology-to-Participate-in-Stifel-Targeted-Oncology-Forum.html

    GLOBENEWSWIRE
    10 Apr 2024
    Share Share
    Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    https://www.globenewswire.com/news-release/2024/04/05/2858455/35186/en/Kura-Oncology-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    05 Apr 2024
    Share Share
    Kura Oncology Reports First Patient Dosed in Trial of KO-2806 Plus Cabozantinib
    Kura Oncology Reports First Patient Dosed in Trial of KO-2806 Plus Cabozantinib

    https://www.globenewswire.com//news-release/2024/03/06/2841290/35186/en/Kura-Oncology-Reports-First-Patient-Dosed-in-Trial-of-KO-2806-Plus-Cabozantinib-in-Renal-Cell-Carcinoma.html

    GLOBENEWSWIRE
    06 Mar 2024
    Share Share
    Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    https://www.globenewswire.com//news-release/2024/03/01/2839093/35186/en/Kura-Oncology-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    01 Mar 2024
    Share Share
    Kura Oncology Reports Fourth Quarter and Full Year 2023 Financial Results
    Kura Oncology Reports Fourth Quarter and Full Year 2023 Financial Results

    https://www.globenewswire.com//news-release/2024/02/27/2836414/35186/en/Kura-Oncology-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results.html

    GLOBENEWSWIRE
    27 Feb 2024
    Share Share
    Kura Doses First Patient in KOMET-008 Trial of Ziftomenib with Standards of Care
    Kura Doses First Patient in KOMET-008 Trial of Ziftomenib with Standards of Care

    https://www.globenewswire.com//news-release/2024/02/26/2835033/35186/en/Kura-Oncology-Doses-First-Patient-in-KOMET-008-Trial-of-Ziftomenib-in-Combination-with-Standards-of-Care-Including-FLT3-Inhibitor-in-Acute-Myeloid-Leukemia.html

    GLOBENEWSWIRE
    26 Feb 2024
    Share Share
    Kura Oncology to Participate in Three Upcoming Investor Conferences
    Kura Oncology to Participate in Three Upcoming Investor Conferences

    https://www.globenewswire.com//news-release/2024/02/22/2833567/35186/en/Kura-Oncology-to-Participate-in-Three-Upcoming-Investor-Conferences.html

    GLOBENEWSWIRE
    22 Feb 2024
    Share Share
    Kura Oncology to Report Fourth Quarter and Full Year 2023 Financial Results
    Kura Oncology to Report Fourth Quarter and Full Year 2023 Financial Results

    https://www.globenewswire.com//news-release/2024/02/20/2831705/35186/en/Kura-Oncology-to-Report-Fourth-Quarter-and-Full-Year-2023-Financial-Results.html

    GLOBENEWSWIRE
    20 Feb 2024
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search